{
  "kind": "treatment",
  "slug": "tianeptine-stablon",
  "type": "medication",
  "name": "Tianeptine",
  "summary": "Tianeptine (Stablon) is an atypical antidepressant used primarily for the treatment of major depressive disorder.",
  "description": "Tianeptine, marketed under the brand name Stablon, is an atypical antidepressant with unique pharmacological properties. Unlike conventional SSRIs, tianeptine enhances serotonin uptake in the brain and modulates glutamatergic activity. It also exhibits neuroplasticity-promoting effects and may reduce stress-induced changes in the brain. Tianeptine is approved in several countries for major depressive disorder but is not FDA-approved in the United States. It is generally well-tolerated but has a potential for misuse at high doses.",
  "category": "medications/psychiatry",
  "tags": [
    "antidepressant",
    "atypical antidepressant",
    "mood disorder"
  ],
  "metadata": {
    "drug_classes": [
      "Atypical antidepressant"
    ],
    "therapeutic_categories": [
      "Psychiatry"
    ],
    "mechanism_categories": [
      "Other"
    ],
    "administration_routes": [
      "Oral"
    ],
    "prescription_status": "Prescription only (in approved countries)",
    "controlled_substance": false,
    "generic_available": true,
    "brand_names": [
      "Stablon",
      "Coaxil",
      "Tatinol"
    ],
    "age_groups": [
      "Adult"
    ],
    "treatment_duration": [
      "Long-term maintenance",
      "Acute treatment"
    ],
    "specialty_areas": [
      "Psychiatry",
      "Mood disorders"
    ],
    "fda_approval_year": 1988
  },
  "clinical_metadata": {
    "primary_indications": [
      "Depression"
    ],
    "off_label_uses": [
      "Anxiety disorders",
      "Irritable bowel syndrome",
      "Asthma-related mood symptoms"
    ],
    "contraindications": [
      "Hypersensitivity to tianeptine or formulation components",
      "Concomitant use with MAO inhibitors"
    ],
    "monitoring_required": [
      "Mood and behavioral changes",
      "Signs of misuse or dependence"
    ],
    "efficacy_rating": {
      "Major depressive disorder": 3
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "tianeptine",
      "Stablon",
      "antidepressant"
    ],
    "synonyms": [
      "Stablon",
      "Coaxil",
      "Tatinol"
    ],
    "common_misspellings": [
      "tianeptin",
      "tianaptine",
      "tianetin"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Treatment of major depressive disorder"
      ]
    },
    {
      "type": "mechanism",
      "text": "Enhances serotonin reuptake in the brain, modulates glutamatergic transmission, and promotes neuroplasticity, which may contribute to its antidepressant effects."
    },
    {
      "type": "dosing",
      "adult": {
        "oral": "Typically 12.5 mg three times daily."
      },
      "pediatric": {
        "oral": "Safety and efficacy not established."
      }
    },
    {
      "type": "dosage_forms",
      "items": [
        "Tablets: 12.5 mg"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Therapeutic effects generally observed within 1â€“2 weeks; sustained benefit with continued use."
    },
    {
      "type": "adverse_effects",
      "common": [
        "nausea",
        "constipation",
        "dizziness",
        "headache",
        "dry mouth"
      ],
      "less_common": [
        "abdominal pain",
        "insomnia",
        "vivid dreams"
      ],
      "serious": [
        "misuse and dependence potential",
        "withdrawal symptoms at high doses"
      ]
    },
    {
      "type": "warnings",
      "other": [
        "Risk of misuse and dependence, especially at doses exceeding recommendations",
        "Monitor for suicidal ideation, particularly in early treatment",
        "Use caution in patients with a history of substance use disorder"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "MAO inhibitors",
          "risk": "Serotonin syndrome or hypertensive crisis",
          "action": "Contraindicated; allow 14-day washout"
        },
        {
          "with": "CNS depressants",
          "risk": "Additive sedation",
          "action": "Monitor closely"
        },
        {
          "with": "Alcohol",
          "risk": "Increased CNS depression",
          "action": "Avoid combination"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "Mood and mental status",
        "Signs of misuse or withdrawal",
        "Gastrointestinal tolerance"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Use only if benefit outweighs risk; limited human data",
      "lactation": "Unknown excretion in human milk; caution advised",
      "geriatrics": "Lower doses may be required due to altered pharmacokinetics"
    },
    {
      "type": "tapering",
      "text": "Gradual dose reduction is recommended to avoid withdrawal symptoms, particularly after prolonged use."
    },
    {
      "type": "clinical_notes",
      "items": [
        "Unique among antidepressants for enhancing serotonin reuptake rather than inhibiting it",
        "Potential for misuse at high doses; associated with opioid-like effects",
        "Not approved in the U.S., but available in parts of Europe, Asia, and Latin America"
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "Stablon Prescribing Information",
          "url": "https://www.vidal.fr/medicaments/gammes/stablon-3561.html"
        },
        {
          "label": "PubChem - Tianeptine",
          "url": "https://pubchem.ncbi.nlm.nih.gov/compound/Tianeptine"
        },
        {
          "label": "NHS - Tianeptine",
          "url": "https://www.nhs.uk/medicines/tianeptine/"
        }
      ]
    }
  ],
  "seo": {
    "title": "Tianeptine (Stablon) - Uses, Dosage, Side Effects, and Warnings",
    "description": "Tianeptine (Stablon) is an atypical antidepressant for major depressive disorder. Learn about dosing, side effects, interactions, and precautions."
  }
}
